Use of Cardiopulmonary Bypass for Treatment of Malignant Hyperthermia.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of cardiothoracic and vascular anesthesia"
DOI: 10.1053/j.jvca.2019.11.010
Abstract: Abstract MALIGNANT HYPERTHERMIA (MH) is a well-described and known complication of modern anesthesia, with volatile anesthestics and succinylcholine recognized as triggering agents. Incidence rates vary, but it is estimated to occur in 1:50,000-100,000 individuals undergoing… read more here.
Keywords: hyperthermia; treatment; cardiopulmonary bypass; use cardiopulmonary ... See more keywords
Vitamin D and Postoperative Vasopressor Use in Cardiopulmonary Bypass
Sign Up to like & getrecommendations! Published in 2018 at "Clinical and Applied Thrombosis/Hemostasis"
DOI: 10.1177/1076029618772357
Abstract: The use of cardiopulmonary bypass (CPB) in cardiac surgery often leads to a systemic inflammatory response. Up to 25% of patients undergoing CPB for cardiac surgery are reported to develop vasoplegic syndrome in the acute… read more here.
Keywords: postoperative vasopressor; use; use cardiopulmonary; vasopressor use ... See more keywords